Article
In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Oct 2012
Humphries Romney M, Fang Ferric C, Aarestrup Frank M, Hindler Janet A
Abstract excerpt
Fluoroquinolone (FQ) resistance in Salmonella enterica is a significant clinical concern. Recognition of resistance by the clinical laboratory is complicated by the multiple FQ resistance mechanisms found in Salmonella. The Clinical Laboratory Standards Institute (CLSI) recently addressed this issue by revising the ciprofloxacin break points for Salmonella species. It is critical for clinicians and laboratory...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
